Total raised
$6.7M
Last: Series A 2022-03
Stage
Series A
Founded
2018
Headcount
5
HQ
Ramat Gan
Sector
Health Tech & Life Sciences
About
NeuroGenesis is a clinical-stage cellular therapy company that focuses on utilizing a proprietary subpopulation of bone marrow stem cells. These cells are specifically selected and enhanced to become remyelinating and regenerative biofactory cells. The company's platform, NG CELL technology, is specifically designed to treat central nervous system diseases, such as progressive multiple sclerosis and amyotrophic lateral sclerosis.
Funding history · 1 round · $6.7M total
2022-03
Series A
$6.7M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesHealthcare
Business model
B2B
Tags
pharmaceuticalscell-therapyamyotrophic-lateral-sclerosis-als